Validation of a Nomogram Predicting Survival After Trimodality Therapy for Esophageal Cancer

Lucas Goense(St. Antonius Ziekenhuis), Steven H. Lin(The University of Texas MD Anderson Cancer Center), Richard van Hillegersberg(University Medical Center Utrecht), Christopher L. Hallemeier(Mayo Clinic in Arizona), Jelle P. Ruurda(University Medical Center Utrecht), Kenneth W. Merrell(Mayo Clinic), Gert J. Meijer(University Medical Center Utrecht), Wayne L. Hofstetter(The University of Texas MD Anderson Cancer Center), Andrea Arnett(Mayo Clinic)
The Annals of Thoracic Surgery
June 19, 2018
10.1016/j.athoracsur.2018.05.055
Cited by 29

Related Papers

Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Integrating genomic features for non-invasive early lung cancer detection
|Nature|2020|689
Neuropeptide S
|Neuron|2004|516
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer
|Nature Cancer|2020|369